This funding opportunity supports exploratory clinical trials in arthritis, musculoskeletal, and skin diseases under the R61 clinical trial mechanism. It requires applicants to conduct clinical trials and comply with NIH simplified review policies. Eligible applicants include a broad range of U.S. organizations, including nonprofits, government entities, educational institutions, and tribal organizations. Foreign organizations are not eligible, but foreign components of U.S. organizations are allowed.
Eligible applicants include a wide range of U.S. organizations such as nonprofits, government entities, educational institutions, small businesses, and tribal organizations. Foreign organizations are not eligible, but foreign components of U.S. organizations are allowed.
